70.69
price down icon1.05%   -0.75
after-market 시간 외 거래: 71.00 0.31 +0.44%
loading
전일 마감가:
$71.44
열려 있는:
$70.61
하루 거래량:
1.65M
Relative Volume:
1.15
시가총액:
$13.53B
수익:
$2.75B
순이익/손실:
$322.29M
주가수익비율:
42.33
EPS:
1.67
순현금흐름:
$300.88M
1주 성능:
-1.81%
1개월 성능:
-0.66%
6개월 성능:
+0.57%
1년 성능:
-19.06%
1일 변동 폭
Value
$69.05
$71.28
1주일 범위
Value
$69.05
$73.18
52주 변동 폭
Value
$60.63
$94.85

바이오마린 Stock (BMRN) Company Profile

Name
명칭
Biomarin Pharmaceutical Inc
Name
전화
(415) 506-6700
Name
주소
105 DIGITAL DRIVE, NOVATO, CA
Name
직원
3,401
Name
트위터
Name
다음 수익 날짜
2024-10-29
Name
최신 SEC 제출 서류
Name
BMRN's Discussions on Twitter

BMRN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
BMRN
Biomarin Pharmaceutical Inc
70.69 13.53B 2.75B 322.29M 300.88M 1.67
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

바이오마린 Stock (BMRN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-02-24 업그레이드 Oppenheimer Perform → Outperform
2024-11-15 개시 Wolfe Research Outperform
2024-10-30 다운그레이드 William Blair Outperform → Mkt Perform
2024-10-10 재개 Raymond James Outperform
2024-08-20 업그레이드 Bernstein Mkt Perform → Outperform
2024-05-17 다운그레이드 Robert W. Baird Outperform → Neutral
2024-05-14 개시 Evercore ISI Outperform
2023-11-15 개시 Wells Fargo Overweight
2023-10-23 업그레이드 Bernstein Underperform → Mkt Perform
2023-09-28 개시 Raymond James Mkt Perform
2023-09-18 개시 UBS Buy
2023-07-27 개시 Scotiabank Sector Perform
2023-07-05 업그레이드 BMO Capital Markets Market Perform → Outperform
2023-06-14 재개 Credit Suisse Outperform
2023-03-21 개시 Bernstein Underperform
2023-02-22 다운그레이드 Oppenheimer Outperform → Perform
2023-02-21 개시 Citigroup Neutral
2023-01-30 개시 BMO Capital Markets Market Perform
2023-01-18 개시 Canaccord Genuity Hold
2022-10-31 업그레이드 Oppenheimer Perform → Outperform
2022-07-13 개시 Cantor Fitzgerald Overweight
2022-06-13 재개 Wedbush Neutral
2022-04-25 업그레이드 Morgan Stanley Equal-Weight → Overweight
2021-11-22 업그레이드 William Blair Mkt Perform → Outperform
2021-10-07 재개 Jefferies Buy
2021-09-09 업그레이드 Stifel Hold → Buy
2021-06-04 재개 Robert W. Baird Outperform
2021-04-26 재개 Credit Suisse Outperform
2021-03-04 재개 Guggenheim Buy
2021-03-01 업그레이드 Evercore ISI In-line → Outperform
2020-08-20 다운그레이드 Citigroup Buy → Neutral
2020-08-20 다운그레이드 William Blair Outperform → Mkt Perform
2020-08-19 다운그레이드 Evercore ISI Outperform → In-line
2020-08-19 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2020-08-19 다운그레이드 Stifel Buy → Hold
2020-07-08 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2020-07-06 재확인 Citigroup Buy
2020-01-28 개시 BMO Capital Markets Market Perform
2020-01-27 개시 BMO Capital Markets Market Perform
2020-01-24 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2019-11-27 업그레이드 Barclays Equal Weight → Overweight
2019-11-12 개시 SunTrust Buy
2019-10-17 재개 BofA/Merrill Buy
2019-05-23 재개 Citigroup Buy
2019-04-09 재개 Raymond James Outperform
2019-01-02 다운그레이드 Raymond James Outperform → Mkt Perform
2018-12-14 개시 Wolfe Research Outperform
2018-10-01 개시 Cantor Fitzgerald Overweight
2018-08-07 재확인 Stifel Buy
2018-08-03 재확인 Stifel Buy
모두보기

바이오마린 주식(BMRN)의 최신 뉴스

pulisher
07:26 AM

The Price Is Right For BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - simplywall.st

07:26 AM
pulisher
Mar 30, 2025

11 Best Gene Therapy Stocks to Buy According to Analysts - Insider Monkey

Mar 30, 2025
pulisher
Mar 28, 2025

US FDA approves Sanofi's bleeding disorder therapy - MarketScreener

Mar 28, 2025
pulisher
Mar 28, 2025

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Momentum Stock - Yahoo Finance

Mar 28, 2025
pulisher
Mar 25, 2025

Is BioMarin Pharmaceutical Inc. (BMRN) a Promising Biotech Stock According to Wall Street Analysts - Insider Monkey

Mar 25, 2025
pulisher
Mar 22, 2025

Insider Sell Alert: Erin Burkhart Sells Shares of Biomarin Pharm - GuruFocus

Mar 22, 2025
pulisher
Mar 21, 2025

BioMarin (BMRN) Up 4.2% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Mar 21, 2025
pulisher
Mar 21, 2025

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock - Yahoo Finance

Mar 21, 2025
pulisher
Mar 21, 2025

Q4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN) - Yahoo Finance

Mar 21, 2025
pulisher
Mar 21, 2025

BioMarin pharmaceutical CAO Erin Burkhart sells $92,618 in stock By Investing.com - Investing.com Australia

Mar 21, 2025
pulisher
Mar 20, 2025

BioMarin pharmaceutical CAO Erin Burkhart sells $92,618 in stock - Investing.com India

Mar 20, 2025
pulisher
Mar 20, 2025

Citi maintains Neutral on BioMarin stock, price target at $82 - Investing.com

Mar 20, 2025
pulisher
Mar 20, 2025

BioMarin Pharmaceutical (BMRN): Among Paul Singer’s Latest Portfolio’s Top Stock Picks - Insider Monkey

Mar 20, 2025
pulisher
Mar 20, 2025

BioMarin Presents New Data Demonstrating Favorable Safety and Strong Adherence in Real-World Clinical Practice with VOXZOGO® (vosoritide) in Children Under 3 with Achondroplasia at 2025 American College of Medical Genetics and Genomics (ACMG) - PR Newswire

Mar 20, 2025
pulisher
Mar 18, 2025

BMRN vs. CSLLY: Which Stock Should Value Investors Buy Now? - Yahoo Finance

Mar 18, 2025
pulisher
Mar 18, 2025

Is BioMarin Pharmaceutical (BMRN) the Best Biotech Stock According to Billionaires? - Yahoo Finance

Mar 18, 2025
pulisher
Mar 17, 2025

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock - Yahoo Finance

Mar 17, 2025
pulisher
Mar 16, 2025

15 Best Biotech Stocks to Buy According to Billionaires - Insider Monkey

Mar 16, 2025
pulisher
Mar 12, 2025

Is BioMarin (BMRN) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance

Mar 12, 2025
pulisher
Mar 12, 2025

SpringWorks Shares Rise More Than 30% in 3 Months: Here's Why - TradingView

Mar 12, 2025
pulisher
Mar 12, 2025

Wall Street Analysts Believe BioMarin (BMRN) Could Rally 36.57%: Here's is How to Trade - Yahoo Finance

Mar 12, 2025
pulisher
Mar 12, 2025

Why BioMarin Pharmaceutical (BMRN) is a Top Momentum Stock for the Long-Term - Yahoo Finance

Mar 12, 2025
pulisher
Mar 12, 2025

544 Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Purchased by SBI Securities Co. Ltd. - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

Smartleaf Asset Management LLC Increases Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - Defense World

Mar 11, 2025
pulisher
Mar 10, 2025

4 Discounted PEG Stocks Offering the Best Returns to Value Investors - Yahoo Finance

Mar 10, 2025
pulisher
Mar 10, 2025

BioMarin Pharmaceutical (NASDAQ:BMRN) Upgraded at StockNews.com - Defense World

Mar 10, 2025
pulisher
Mar 09, 2025

BioMarin Pharmaceutical Inc. to Host Earnings Call - ACCESS Newswire

Mar 09, 2025
pulisher
Mar 09, 2025

Proficio Capital Partners LLC Takes Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - Defense World

Mar 09, 2025
pulisher
Mar 07, 2025

The Top 12 Companies Hiring in Biopharma Now - BioSpace

Mar 07, 2025
pulisher
Mar 06, 2025

BioMarin at TD Cowen Conference: Strategic Growth and Innovation - Investing.com

Mar 06, 2025
pulisher
Mar 05, 2025

First Week of October 17th Options Trading For BioMarin Pharmaceutical (BMRN) - Nasdaq

Mar 05, 2025
pulisher
Mar 05, 2025

Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term - Yahoo Finance

Mar 05, 2025
pulisher
Mar 05, 2025

Phenylketonuria Treatment Market Projected To Witness Substantial Growth, 2025-2032: BioMarin Pharmaceutical - EIN News

Mar 05, 2025
pulisher
Mar 05, 2025

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Given Average Rating of “Moderate Buy” by Analysts - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

The Strong Earnings Posted By BioMarin Pharmaceutical (NASDAQ:BMRN) Are A Good Indication Of The Strength Of The Business - Simply Wall St

Mar 04, 2025
pulisher
Mar 04, 2025

Statutory Profit Doesn't Reflect How Good BioMarin Pharmaceutical's (NASDAQ:BMRN) Earnings Are - Yahoo Finance

Mar 04, 2025
pulisher
Mar 04, 2025

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by Sanctuary Advisors LLC - Defense World

Mar 04, 2025
pulisher
Mar 01, 2025

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Position Lessened by Handelsbanken Fonder AB - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

Los Angeles Capital Management LLC Purchases 28,431 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Fjarde AP Fonden Fourth Swedish National Pension Fund Boosts Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

BMRN or CSLLY: Which Is the Better Value Stock Right Now? - Yahoo Finance

Feb 28, 2025
pulisher
Feb 28, 2025

Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term - Yahoo Finance Australia

Feb 28, 2025
pulisher
Feb 28, 2025

New York State Common Retirement Fund Has $6.16 Million Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Cantor Fitzgerald Has Positive View of BMRN FY2025 Earnings - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Oppenheimer Upgrades BioMarin Pharmaceutical (NASDAQ:BMRN) to "Outperform" - MarketBeat

Feb 28, 2025
pulisher
Feb 27, 2025

Investor Network: BioMarin Pharmaceutical Inc. to Host Earnings Call - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 27, 2025

Q2 Earnings Estimate for BMRN Issued By Leerink Partnrs - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

Research Analysts Set Expectations for BMRN Q1 Earnings - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

Global Retirement Partners LLC Increases Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - Defense World

Feb 27, 2025
pulisher
Feb 27, 2025

BioMarin Pharmaceutical earnings rise 16% in Q4 - North Bay Business Journal

Feb 27, 2025
pulisher
Feb 26, 2025

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) CAO Erin Burkhart Sells 1,344 Shares - MarketBeat

Feb 26, 2025

바이오마린 (BMRN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
자본화:     |  볼륨(24시간):